08.06.2018 • NewsArkemaElaine Burridge

Arkema Studies US Thiochemicals Expansion

Arkema Studies US Thiochemicals Expansion
Arkema Studies US Thiochemicals Expansion

Arkema is studying the doubling of thiochemicals capacity at its site in Beaumont, Texas, USA. The additional capacity would supply high value-added sulfur derivatives to Novus International’s proposed methionine hydroxyl analogue plant in Calhoun County, Texas.

The French group said the thiochemicals project will support rising global demand for methionine, an essential amino acid for animal nutrition, which should reach an annual growth rate of 6% over the coming years.

The new plant is expected to go on stream by the summer of 2021. A final investment decision should be made at the end of this year.

Novus announced last November its intention to build a 120,000 t/y methionine plant at Ineos Nitrile’s Green  Lake site in Calhoun County.  Completion is due in 2020. Newton Manufacturing, a wholly owned subsidiary of Novus International, will own and manage the facility.

Arkema is also expanding thiochemicals capacity at Kerteh, Malaysia. Production of methyl mercaptan, a methionine intermediate, will double when the project completes in 2020.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.